SELLAS Life Sciences (SLS) Other Operating Expenses (2010 - 2023)

SELLAS Life Sciences (SLS) has 14 years of Other Operating Expenses data on file, last reported at $184000.0 in Q1 2023.

• On a quarterly basis, Other Operating Expenses rose 2144.44% year-over-year to $184000.0 in Q1 2023; TTM through Dec 2023 was $184000.0, a 43.21% decrease from a year earlier, with the FY2022 full-year figure at $10.1 million, up 71.19% from the prior year.
• Other Operating Expenses for Q1 2023 stood at $184000.0, up from $124000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for SLS reached as high as $5.7 million in Q4 2021 and fell as low as -$178000.0 in Q1 2019.
• Historically, Other Operating Expenses has averaged $415466.7 across 5 years, with a median of -$18000.0 in 2019.
• Across the five-year window, Other Operating Expenses slumped 668.42% in 2021 and surged 2144.44% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at -$21000.0 in 2019, then jumped by 190.48% to $19000.0 in 2020, then surged by 29900.0% to $5.7 million in 2021, then slumped by 97.82% to $124000.0 in 2022, then soared by 48.39% to $184000.0 in 2023.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $184000.0 in Q1 2023, $124000.0 in Q3 2022, and $209000.0 in Q2 2022.